New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
New Delhi [India], April 12 (ANI): India on Tuesday handed over to Cambodia 325,000 doses of Made in India Covishield vaccines under the Quad Vaccine Partnership scheme.
New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum
Pune (Maharashtra) [India], April 9 (ANI): Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose.
New Delhi [India], March 20 (ANI): The National Technical Advisory Group on Immunization (NTAGI) on Sunday recommended the Union Ministry of Health to reduce the COVID-19 vaccine Covishield's duration of the second dose to somewhere between 8 to 16 weeks after the first dose in view of the o
Washington [US], February 24 (ANI): Microsoft co-founder Bill Gates, at a virtual event of the India-US Health Partnership roundtable on "Vaccine for All", on Tuesday, said that India's 3 vaccines -- Covaxin, Corbavex and Covishield -- were the products of partnerships that bridged sectors a
New Delhi [India], January 27 (ANI): Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permissio
New Delhi [India], January 27 (ANI): The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.
New Delhi [India], January 26 (ANI): The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.
New Delhi [India], January 25 (ANI): Serum Institute of India (SII) Chairman and Managing Director Cyrus Poonawalla will be conferred with Padma Bhushan, announced the Centre on Tuesday, on the eve of the 73rd Republic Day.
New Delhi [India], January 20 (ANI): Indian Council of Medical Research (ICMR) head Dr Balram Bhargava, in a health briefing, on Thursday asserted that deaths have been considerably reduced due to COVID-19 vaccinations in this third surge of the coronavirus infection.
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po